Breaking News Instant updates and real-time market news.

TEVA

Teva

$17.77

-1.35 (-7.06%)

10:53
02/13/19
02/13
10:53
02/13/19
10:53

Teva's 2019 more challenging than Street was expecting, says Wells Fargo

Wells Fargo analyst David Maris said that while management comments on the call lead him to believe that Teva's well below consensus guidance for 2019 may be a worst case scenario, it still indicates that 2019 will be more challenging than Wall Street had been expecting. The guidance "points to why our caution ahead of the quarter was well grounded," Maris tells investors, noting that while he'd previously said he thought consensus was too high, he did not expect the magnitude of this shortfall. Maris keeps a Market Perform rating on Teva shares, which are down 7.6% to $17.66 in morning trading.

  • 13

    Feb

TEVA Teva
$17.77

-1.35 (-7.06%)

01/23/19
01/23/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Walmart (WMT) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Simeon Gutman citing his belief that Walmart U.S. can now generate sales growth without sacrificing margins, unlike most retailers. 2. Teva (TEVA) upgraded to Buy from Neutral at UBS and to Neutral from Underweight at Piper Jaffray. 3. D.R. Horton (DHI) upgraded to Buy from Neutral at Mizuho with analyst Haendel St. Juste saying stock selectivity is becoming more important in these latter stages of the housing cycle and larger platforms with price point diversification and strong balance sheets will be rewarded. 4. Logitech (LOGI) upgraded to Overweight from Neutral at JPMorgan and to Hold from Sell at Maxim. 5. Lamb Weston (LW) upgraded to Buy from Hold at Stifel with analyst Christopher Growe saying he is confident in the "growth profile of the business continuing amidst the very strong operating conditions in the category." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/25/19
PIPR
01/25/19
NO CHANGE
PIPR
Report that CVS excluded Amgen's Aimovig 'greatly exaggerated,' says Piper
Piper Jaffray analyst Christopher Raymond kept an Overweight rating and $220 price target on Amgen (AMGN) following a Reuters report from earlier on Friday which stated that CVS (CVS) has excluded Amgen's Aimovig from its formulary. The analyst called the report "Friday afternoon clickbait" and noted that while CVS currently provides preferred status to Teva's (TEVA) Ajovy and Eli Lilly's (LLY) Emgality, this was made public in late 2018. In a check with management, Raymond found out the decision only encompasses about one-third of CVS network, that CVS is actively working to improve this access, and that 70% of commercial migraine patients have contracted access to Aimovig. Raymond concluded that this was "not something to worry about" in his view, and did not change his Q4, FY19, or FY20 estimates on Aimovig. In Friday trading, shares of Amgen were down just over 1% to $198.77.
01/30/19
WELS
01/30/19
NO CHANGE
WELS
Wells says Novartis report read-through 'neutral to negative' for Mylan, Teva
After Novartis' (NVS) Sandoz generics unit reported Q4 sales were down 2% in constant currency, due to a 7% decline in price and 5% increase in volume, Wells Fargo analyst David Maris noted that the majority of the price erosion came from the U.S. While the 2% decline was a sequential improvement from down 4% in Q3, Novartis was up against an easy comparison in the year ago period, Maris added. His view is that the U.S. generic market has not materially changed or improved at this point and he contends the report has a "neutral to negative read-through" relative to investors' expectations for Mylan (MYL) and Teva (TEVA).
02/01/19
WELS
02/01/19
NO CHANGE
Target $46
WELS
Market Perform
Perrigo's ProAir opportunity 'may be vaporizing,' says Wells Fargo
Wells Fargo analyst David Maris noted that GlaxoSmithKline (GSK) launched an authorized generic of Ventolin on January 15 and he has now learned that Teva (TEVA) may have "surprisingly launched" an authorized generic of ProAir in response to the generic Ventolin pressure prior to Perrigo's (PRGO) approval. Pricing pressure from generic Ventolin, in addition to the launch of an authorized generic well ahead of Perrigo's own generic ProAir launch, seem to have significantly diminished Perrigo's generic ProAir opportunity, Maris tells investors. He keeps a Market Perform rating and $46 price target on Perrigo shares.

TODAY'S FREE FLY STORIES

EIG

Employers Holdings

$45.92

-0.03 (-0.07%)

16:49
02/20/19
02/20
16:49
02/20/19
16:49
Hot Stocks
Employers Holdings declared an increased quarterly dividend of 22c »

The company reported that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 08

    Apr

  • 09

    Apr

  • 10

    Apr

GTE

Gran Tierra

$2.34

-0.06 (-2.50%)

16:48
02/20/19
02/20
16:48
02/20/19
16:48
Hot Stocks
Gran Tierra acquires strategic assets in Putumayo, Llanos Basins »

Gran Tierra Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

EIG

Employers Holdings

$45.92

-0.03 (-0.07%)

16:47
02/20/19
02/20
16:47
02/20/19
16:47
Earnings
Employers Holdings reports Q4 EPS 77c, consensus 64c »

The company's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 08

    Apr

  • 09

    Apr

  • 10

    Apr

SXCP

SunCoke Energy Partners

$14.85

0.37 (2.56%)

16:46
02/20/19
02/20
16:46
02/20/19
16:46
Conference/Events
SunCoke Energy Partners management to meet with Seaport Global »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

SXC

SunCoke Energy

$10.32

0.25 (2.48%)

16:45
02/20/19
02/20
16:45
02/20/19
16:45
Conference/Events
SunCoke Energy management to meet with Seaport Global »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

SXC

SunCoke Energy

$10.32

0.25 (2.48%)

16:45
02/20/19
02/20
16:45
02/20/19
16:45
Conference/Events
SunCoke Energy management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

DNOW

NOW Inc.

$15.86

0.57 (3.73%)

16:43
02/20/19
02/20
16:43
02/20/19
16:43
Conference/Events
NOW Inc. management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

EFC

Ellington Financial

$17.15

-0.06 (-0.35%)

16:42
02/20/19
02/20
16:42
02/20/19
16:42
Earnings
Ellington Financial reports Q4 NII 41c, consensus 37c »

Reports Book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

IVR

Invesco Mortgage

$15.88

-0.1 (-0.63%)

16:42
02/20/19
02/20
16:42
02/20/19
16:42
Earnings
Invesco Mortgage reports Q4 core EPS 46c, consensus 41c »

Reports Q4 2018 book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

HTGM

HTG Molecular

$2.39

-0.15 (-5.91%)

16:41
02/20/19
02/20
16:41
02/20/19
16:41
Hot Stocks
HTG Molecular amends its precision diagnostic partnership »

HTG Molecular Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMO

Thermo Fisher

$252.07

1.295 (0.52%)

16:40
02/20/19
02/20
16:40
02/20/19
16:40
Periodicals
Thermo Fisher halts sale of genetic sequencers to Xinjiang area, WSJ says »

Thermo Fisher said it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLIT

Harmonic

$5.32

-0.03 (-0.56%)

16:40
02/20/19
02/20
16:40
02/20/19
16:40
Initiation
Harmonic initiated  »

Harmonic initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDE

Coeur Mining

$5.55

0.045 (0.82%)

16:40
02/20/19
02/20
16:40
02/20/19
16:40
Hot Stocks
Coeur Mining sees FY19 gold output 334K-372K oz vs 359.5K oz in FY18 »

Sees FY19 silver output…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

VEAC

Vantage Energy Acquisition

$10.15

-0.01 (-0.10%)

16:40
02/20/19
02/20
16:40
02/20/19
16:40
Hot Stocks
Breaking Hot Stocks news story on Vantage Energy Acquisition »

Vantage Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:40
02/20/19
02/20
16:40
02/20/19
16:40
Hot Stocks
Breaking Hot Stocks news story  »

Vantage Energy…

TMST

TimkenSteel

$12.34

-0.08 (-0.64%)

16:38
02/20/19
02/20
16:38
02/20/19
16:38
Hot Stocks
Breaking Hot Stocks news story on TimkenSteel »

TimkenSteel sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

Y

Alleghany

$650.80

(0.00%)

16:37
02/20/19
02/20
16:37
02/20/19
16:37
Earnings
Alleghany reports Q4 operating EPS ($4.35), consensus ($5.31) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:37
02/20/19
02/20
16:37
02/20/19
16:37
General news
API crude inventories for week of February 15 »

API reports that crude…

TMST

TimkenSteel

$12.34

-0.08 (-0.64%)

16:37
02/20/19
02/20
16:37
02/20/19
16:37
Hot Stocks
Breaking Hot Stocks news story on TimkenSteel »

TimkenSteel sees Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

KALU

Kaiser Aluminum

$109.77

2.16 (2.01%)

16:37
02/20/19
02/20
16:37
02/20/19
16:37
Earnings
Kaiser Aluminum sees FY19 low to mid-single digit percent increase in shipments »

Overall, for the full…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

CDE

Coeur Mining

$5.55

0.045 (0.82%)

16:36
02/20/19
02/20
16:36
02/20/19
16:36
Hot Stocks
Coeur Mining reports Q4 gold production 92.5K oz vs. 118.8K oz last year »

Reports Q4 silver…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

JKHY

Jack Henry

$132.86

-0.03 (-0.02%)

16:36
02/20/19
02/20
16:36
02/20/19
16:36
Initiation
Jack Henry initiated  »

Jack Henry initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 12

    Mar

TMST

TimkenSteel

$12.34

-0.08 (-0.64%)

16:35
02/20/19
02/20
16:35
02/20/19
16:35
Earnings
TimkenSteel reports Q4 EPS (89c), consensus (6c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

KALU

Kaiser Aluminum

$109.77

2.16 (2.01%)

16:35
02/20/19
02/20
16:35
02/20/19
16:35
Earnings
Kaiser Aluminum reports Q4 EPS $1.77, consensus $1.54 »

Reports Q4 revenue $389M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

CDE

Coeur Mining

$5.55

0.045 (0.82%)

16:34
02/20/19
02/20
16:34
02/20/19
16:34
Earnings
Coeur Mining reports Q4 EPS 8c, consensus (11c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.